CNTXHIGH SIGNALFINANCIAL10-K

CNTX shows deteriorating financial performance with substantially higher losses and severely constrained operating cash flow amid a declining cash position.

The company's operating losses expanded meaningfully while operating cash flow deteriorated substantially, indicating worsening operational efficiency and cash generation capabilities. The 30% decline in cash reserves to $66 million, combined with the significantly negative operating cash flow, raises questions about the company's ability to sustain current operations without additional financing.

Comparing 2026-03-23 vs 2025-03-20View on EDGAR →
FINANCIAL ANALYSIS

CNTX experienced a challenging fiscal year with operating losses expanding from $29.9M to $39.7M and net losses increasing from $26.7M to $36.1M. Operating cash flow deteriorated substantially from negative $14.6M to negative $26.4M, signaling serious operational cash generation issues. The company's financial position weakened considerably with total assets declining 30% to $68.5M and cash reserves falling to $66.0M from $94.4M, though interest expense dropped significantly from $661K to $64K.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
-90.3%
$661K$64K

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Operating Cash Flow
Cash Flow
-81.3%
-$14.6M-$26.4M

Operating cash flow fell 81.3% — earnings quality concerns; investigate working capital changes and non-cash items.

Stockholders Equity
Balance Sheet
-36.5%
$95.3M$60.5M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Net Income
P&L
-35.2%
-$26.7M-$36.1M

Net income declined 35.2% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-32.7%
-$29.9M-$39.7M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Total Assets
Balance Sheet
-30.2%
$98.1M$68.5M

Total assets contracted 30.2% — asset sales, write-downs, or balance sheet optimization underway.

Current Assets
Balance Sheet
-30.2%
$97.9M$68.4M

Current assets declined 30.2% — monitor working capital adequacy and short-term liquidity.

Cash & Equivalents
Balance Sheet
-30.1%
$94.4M$66.0M

Cash declined 30.1% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

LANGUAGE CHANGES
NEW — 2026-03-23
PRIOR — 2025-03-20
ADDED
As of March 19, 2026, the registrant had 91,879,177 shares of common stock, $0.001 par value per share, outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 61 Item 7A.
Inflation, geopolitical developments, global supply chain disruptions and public health concerns could adversely affect our business and results of operations.
trade policy, including the imposition of tariffs and the resulting consequences, may have a material adverse impact on our business, financial condition, and results of operations.
If we are unable to obtain sufficient quantities of raw materials and supplies, at acceptable prices and on a timely basis, it could harm our business.
+7 more — sign up free →
REMOVED
As of March 18, 2025, the registrant had 89,704,194 shares of common stock, $0.001 par value per share, outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 58 Item 7A.
Inflation could adversely affect our business and results of operations.
We may issue debt and equity securities, which are senior to our common stock as to distributions and in liquidation, which could materially adversely affect the market price of our common stock.
We may fail to maintain effective internal control over financial reporting and effective disclosure controls and procedures.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →